Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ryan G. Casner"'
Autor:
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Jian Yu, Yicheng Guo, Maple Wang, Jasper F.-W. Chan, Gabriele Cerutti, Sho Iketani, Lihong Liu, Zizhang Sheng, Zhiwei Chen, Kwok-Yung Yuen, Peter D. Kwong, Yaoxing Huang, Lawrence Shapiro, David D. Ho
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 147-157 (2022)
The repeated emergence of highly pathogenic human coronaviruses as well as their evolving variants highlight the need to develop potent and broad-spectrum antiviral therapeutics and vaccines. By screening monoclonal antibodies (mAbs) isolated from CO
Externí odkaz:
https://doaj.org/article/bd6b1f73dd464708ab57777f7213a125
Autor:
Luke L. McGoldrick, Appu K. Singh, Lusine Demirkhanyan, Ting-Yu Lin, Ryan G. Casner, Eleonora Zakharian, Alexander I. Sobolevsky
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Transient receptor potential (TRP) channels are ubiquitous occurring cation-selective sensory ion channels that respond to various stimuli. Here the authors characterize crTRP1 from the alga Chlamydomonas reinhardtii, present its 3.5 Å cryo-EM struc
Externí odkaz:
https://doaj.org/article/63a0a3a8fc3a440ba91ed9cb0c51a78f
Autor:
Vikas Chonira, Young D. Kwon, Jason Gorman, James Brett Case, Zhiqiang Ku, Rudo Simeon, Ryan G. Casner, Darcy R. Harris, Adam S. Olia, Tyler Stephens, Lawrence Shapiro, Michael F. Bender, Hannah Boyd, I-Ting Teng, Yaroslav Tsybovsky, Florian Krammer, Ningyan Zhang, Michael S. Diamond, Peter D. Kwong, Zhiqiang An, Zhilei Chen
Publikováno v:
Nature Chemical Biology. 19:284-291
Autor:
Lihong Liu, Ryan G. Casner, Yicheng Guo, Qian Wang, Sho Iketani, Jasper Fuk-Woo Chan, Jian Yu, Bernadeta Dadonaite, Manoj S. Nair, Hiroshi Mohri, Eswar R. Reddem, Shuofeng Yuan, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Kwok-Yung Yuen, Zizhang Sheng, Yaoxing Huang, Jesse D. Bloom, Lawrence Shapiro, David D. Ho
Publikováno v:
bioRxiv
SUMMARYSARS-CoV-2 continues to evolve and evade most existing neutralizing antibodies, including all clinically authorized antibodies. We have isolated and characterized two human monoclonal antibodies, 12-16 and 12-19, which exhibited neutralizing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8dcb7a3556cd7c28fe78eb9ee02c16
https://europepmc.org/articles/PMC10120718/
https://europepmc.org/articles/PMC10120718/
Autor:
Vikas Chonira, Young Do Kwon, Jason Gorman, James Brett Case, Zhiqiang Ku, Rudo Simeon, Ryan G. Casner, Darcy R. Harris, Adam S. Olia, Tyler Stephens, Lawrence Shapiro, Hannah Boyd, Yaroslav Tsybovsky, Florian Krammer, Michael S. Diamond, Peter D. Kwong, Zhiqiang An, Zhilei Chen
Publikováno v:
bioRxiv
We report the engineering and selection of two synthetic proteins – FSR16m and FSR22 – for possible treatment of SARS-CoV-2 infection. FSR16m and FSR22 are trimeric proteins composed of DARPin SR16m or SR22 fused with a T4 foldon and exhibit broa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a36232ef0a00afa679c89ba08211c5b
https://europepmc.org/articles/PMC9176645/
https://europepmc.org/articles/PMC9176645/
Autor:
Lihong Liu, Sho Iketani, Yicheng Guo, Eswar R. Reddem, Ryan G. Casner, Manoj S. Nair, Jian Yu, Jasper F.-W. Chan, Maple Wang, Gabriele Cerutti, Zhiteng Li, Nicholas C. Morano, Candace D. Castagna, Laura Corredor, Hin Chu, Shuofeng Yuan, Vincent Kwok-Man Poon, Chris Chun-Sing Chan, Zhiwei Chen, Yang Luo, Marcus Cunningham, Alejandro Chavez, Michael T. Yin, David S. Perlin, Moriya Tsuji, Kwok-Yung Yuen, Peter D. Kwong, Zizhang Sheng, Yaoxing Huang, Lawrence Shapiro, David D. Ho
Publikováno v:
Science translational medicine. 14(646)
The devastation caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made clear the importance of pandemic preparedness. To address future zoonotic outbreaks due to related viruses in the sarbecovirus subgenus, we identified a h
Autor:
Lihong Liu, Sho Iketani, Yicheng Guo, Ryan G. Casner, Eswar R. Reddem, Manoj S. Nair, Jian Yu, Jasper F-W. Chan, Maple Wang, Gabriele Cerutti, Zhiteng Li, Candace D. Castagna, Laura Corredor, Hin Chu, Shuofeng Yuan, Vincent Kwok-Man Poon, Chris Chun-Sing Chan, Zhiwei Chen, Yang Luo, Marcus Cunningham, Alejandro Chavez, Michael T. Yin, David S. Perlin, Moriya Tsuji, Kwok-Yung Yuen, Peter D. Kwong, Zizhang Sheng, Yaoxing Huang, Lawrence Shapiro, David D. Ho
The devastation caused by SARS-CoV-2 has made clear the importance of pandemic preparedness. To address future zoonotic outbreaks due to related viruses in the sarbecovirus subgenus, we identified a human monoclonal antibody, 10-40, that neutralized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cada6fa965536e3c1a164bde5d12324e
https://doi.org/10.1101/2021.12.11.472236
https://doi.org/10.1101/2021.12.11.472236
Autor:
Bharat Madan, Eswar R. Reddem, Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Yaoxing Huang, Ahmed S. Fahad, Matheus Oliveira Souza, Bailey B. Banach, Sheila N. López Acevedo, Xiaoli Pan, Rajani Nimrania, I‐Ting Teng, Fabiana Bahna, Tongqing Zhou, Baoshan Zhang, Michael T. Yin, David D. Ho, Peter D. Kwong, Lawrence Shapiro, Brandon J. DeKosky
Publikováno v:
Aiche Journal. American Institute of Chemical Engineers
Antiviral monoclonal antibody (mAb) discovery enables the development of antibody-based antiviral therapeutics. Traditional antiviral mAb discovery relies on affinity between antibody and a viral antigen to discover potent neutralizing antibodies, bu
Autor:
Gabriele Cerutti, Jian Yu, Manoj S. Nair, Peter D. Kwong, David D. Ho, Lawrence Shapiro, Lihong Liu, Yaoxing Huang, Maple Wang, Ryan G. Casner, Pengfei Wang
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
Cell Host & Microbe
article-version (status) pre
article-version (number) 1
Cell Host & Microbe
The emergence of SARS-CoV-2 variants has raised concerns about altered sensitivity to antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B.1.1.7 and B.1.351 to antibody neutralization has been recently investigated. We report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939f3d43d7976c6c0bc62cd13444203f
https://doi.org/10.1101/2021.03.01.433466
https://doi.org/10.1101/2021.03.01.433466
Autor:
Jasper Fuk-Woo Chan, Peter D. Kwong, Jian Yu, Lihong Liu, Kwok-Yung Yuen, Yicheng Guo, Ryan G. Casner, Manoj S. Nair, David D. Ho, Zizhang Sheng, Zhiwei Chen, Pengfei Wang, Sho Iketani, Gabriele Cerutti, Lawrence Shapiro, Yaoxing Huang, Maple Wang
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
bioRxiv
article-version (status) pre
article-version (number) 1
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 147-157 (2022)
article-version (VoR) Version of Record
bioRxiv
article-version (status) pre
article-version (number) 1
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 147-157 (2022)
The repeated emergence of highly pathogenic human coronaviruses as well as their evolving variants highlight the need to develop potent and broad-spectrum antiviral therapeutics and vaccines. By screening monoclonal antibodies (mAbs) isolated from CO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bea924c28399ae3047b3471361a5009